Comparison of the European Renal Function Consortium Equation With Chronic Kidney Disease
Epidemiology Collaboration 2021 for Estimating Glomerular Filtration Rate Among Algerian Population With Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.15605/jafes.041.02.6337Keywords:
Type 2 diabetes mellitus, estimated glomerular filtration rate, EKFC equation, CKD-EPI equationAbstract
Introduction. Type 2 diabetes mellitus (T2D) is the leading cause of end stage renal disease. Screening for chronic kidney disease is recommended for early diagnosis and intervention. This requires assessment of renal function by computing for estimated glomerular filtration rate (eGFR) and urine albumin-creatine ratio. Several formulas have been proposed for computation of eGFR. The European Renal Function Consortium (EKFC) equation, obtained by combining the full age spectrum (FAS) and Chronic Kidney Disease – Epidemiology Collaboration 2021 (CKD-EPI) equations, has been proposed as a more universal formula for eGFR. It has the advantage of eliminating correction for ethnicity and covers a wide age range. The aim of this study is to compare the EKFC and CKD-EPI 2021 equations to assess eGFR among Algerian population with T2D.
Methodology. This is an observational, cross-sectional, analytical study. Serum creatinine levels were measured using the Cobas integra 400 Roche diagnostic device. The results were used to estimate GFR using the two formulas: CKD-EPI 2021 and EKFC.
Results. There was a statistically significant difference between the performance of the CKD-EPI 2021 and EKFC equations (p <0.001). However, there was a very good correlation (r = 0.99) even though the EKFC underestimates eGFR compared to CKD-EPI 2021 (bias: -8 ml/min/1.73 m²).
Conclusions. The main value of the EKFC lies in its ability to provide a detailed stratification in the early stages of chronic kidney disease. Our study also represents the first attempt to establish the q-value in the Algerian population.
Downloads
References
1. Bouattar T, Ahid S, Benasila S, et al. [The factors for progression of the diabetic nephropathy: management and evolution]. Nephrol Ther. 2009;5(3):181–7. https://pubmed.ncbi.nlm.nih.gov/19269914 https://doi.org/10.1016/j.nephro.2008.12.004
2. Bouenizabila E, Loumingou R, Motoula M, Andzouana N, Monabeka HG. Diabetic nephropathy at Brazzaville University Hospital, Congo: Epidemiological and clinical aspects, and risk factors. Med Mal Metab. 2015 ;9(2):220–6. https://doi.org/10.1016/S1957-2557(15)30048-1
3. El Yamani N, Zerrouki D, Berrabeh S, Benouda S, Rouf S, Latrech H. La néphropathie diabétique dans le diabète de type 1: Profil épidémiologique à propos de 36 cas. Annales d’Endocrinologie. 2021;82(5):527. https://doi.org/10.1016/j.ando.2021.08.807
4. Levey AS, De Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int. 2011 ;80(1):17–28. https://pubmed.ncbi.nlm.nih.gov/21150873 https://doi.org/10.1038/ki.2010.483
5. Halimi JM, Hadjadj S, Aboyans V, et al. [Microalbuminuria and urinary albumin excretion: clinical practice guidelines]. Nephrol Ther. https://doi.org/10.1016/j.nephro.2007.05.001
6. Brown S. Measurement of Glomerular Filtration Rate (GFR). In: Payne S, Eardley I, O’Flynn K, editors. Imaging and Technology in Urology. London: Springer London; 2012. https://doi.org/10.1007/978-1-4471-2422-1_30
7. Dussol B. Méthodes d’exploration de la fonction rénale: Intérêt et limites des formules permettant d’estimer la fonction rénale. Immuno-analyse & Biologie Spécialisée. 2011;26(1):6–12. https://doi.org/10.1016/j.immbio.2010.12.001
8. Schmidt RL, Straseski JA, Raphael KL, Adams AH, Lehman CM. A risk assessment of the Jaffe vs enzymatic method for creatinine measurement in an outpatient population. PLoS ONE. 2015;10(11):e0143205. https://pubmed.ncbi.nlm.nih.gov/26599086 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657986 https://doi.org/10.1371/journal.pone.0143205
9. Summary of recommendation statements. Kidney Int Suppl (2011). 2013;3(1):5–14. https://pubmed.ncbi.nlm.nih.gov/25598998 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284512 https://doi.org/10.1038/kisup.2012.77
10. Braimoh RW, Ediale TI, Mabayoje MO, Ale OK, Bello BT, Amira CO. Comparison of CKD-EPI, C-G and MDRD equations for estimating glomerular filtration rate in chronic kidney disease population in South-Western Nigeria. REJHS. 2023;11(4):285–95. https://doi.org/10.4314/REJHS.V11I4.1
11. Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and cystatin c–based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–49. https://pubmed.ncbi.nlm.nih.gov/34554658 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822996 https://doi.org/10.1056/NEJMoa2102953
12. Pottel H, Björk J, Courbebaisse M, et al. Development and validation of a modified full age spectrum creatinine-based equation to estimate Glomerular Filtration Rate: A cross-sectional. Ann Intern Med. 2021;174(2):183–91. https://pubmed.ncbi.nlm.nih.gov/33166224 https://doi.org/10.7326/M20-4366
13. A Vassault, A Hulin, E Chapuzet, J Arnaud, C Giroud; membres du sous-groupe 2 analytique de la SFBC. [Verification/validation of the performances of analytical method]. Ann Biol Clin (Paris). 2010;68(1):247–94. https://pubmed.ncbi.nlm.nih.gov/21613021 https://doi.org/10.1684/abc.2011.0562
14. Rohlfing CL, Hanson S, Tennill AL, Little RR. Effects of whole blood storage on hemoglobin A1c measurements with five current assay methods. Diabetes Technol Ther. 2012;14(3):271–5. https://pubmed.ncbi.nlm.nih.gov/22032202 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464003 https://doi.org/10.1089/dia.2011.0136
15. Delanaye P. Estimation du DFG: quelles recommandations en 2024? [paper presentation]. Premier congrès de la Société Béninoise de Néphrologie; November 27, 2024. https://hdl.handle.net/2268/324940
16. Miller WG, Kaufman HW, Levey AS, et al. National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories. Clin Chem. 2022;68(4):511–20. https://pubmed.ncbi.nlm.nih.gov/34918062 https://doi.org/10.1093/clinchem/hvab278
17. Lu S, Robyak K, Zhu Y. The CKD-EPI 2021 equation and other creatinine-based race-independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging. J Appl Lab Med. 2023;8(5):952–61. https://pubmed.ncbi.nlm.nih.gov/37534520 https://doi.org/10.1093/jalm/jfad047
18. Lee S, Lee GH, Kim H, Yang HS, Hur M. Application of the European Kidney Function Consortium Equation to Estimate Glomerular Filtration Rate: A comparison study of the CKiD and CKD-EPI Equations Using the Korea National Health and Nutrition Examination Survey (KNHANES 2008–2021). Medicina. 2024;60(4):612. https://pubmed.ncbi.nlm.nih.gov/38674258 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11052228 https://doi.org/10.3390/medicina60040612
19. Martins RB, Escott GM, Fagundes SLC, Franciele PI, Tochetto LA, De ABL, et al. Performance of EKFC, FAS and 2021 CKD-EPI equations for estimating glomerular filtration rate in people with type 2 diabetes. EJEA. 2022. https://doi.org/10.1530/endoabs.81.P60
20. Chagnac A, Herman M, Zingerman B, et al. Obesity-induced glomerular hyperfiltration: Its involvement in the pathogenesis of tubular sodium reabsorption. Nephrology Dialysis Transplantation. 2008 ;23(12):3946–52. https://pubmed.ncbi.nlm.nih.gov/18622024 https://doi.org/10.1093/ndt/gfn379
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Zohra Sedoud, Feriel Yasmine Baghdali, Arzour Hind, Ouzriat Massinissa, Deghima Sabrine, Haddoum Farid, Djenouhat Kamel

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.






